By Josh White
Date: Friday 01 Nov 2024
(Sharecast News) - Ondine Biomedical announced a proposed minimum £8.5m fundraising through a placing and subscription of new shares on Friday, priced at 8.5p each, to support the US phase three clinical trial of its nasal photodisinfection system, 'Steriwave'.
By Josh White
Date: Friday 18 Oct 2024
(Sharecast News) - Ondine Biomedical announced on Friday that it has received regulatory approval to market its 'Steriwave' nasal decolonisation technology in the United Arab Emirates.
By Josh White
Date: Friday 21 Jun 2024
(Sharecast News) - Life science company Ondine Biomedical announced on Friday that its 'Steriwave' nasal photodisinfection treatment was now available through the NHS Supply Chain.
Currency | UK Pounds |
Share Price | 8.13p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 10.50p |
52 Week Low | 5.13p |
Volume | 10,000 |
Shares Issued | 394.08m |
Market Cap | £32.02m |
Beta | 0.89 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
15:33 | 10,000 @ 8.00p |
Chair | Jean Charest |
CEO | Carolyn Cross |
You are here: research